CRP has little incremental value over traditional cardiovascular risk factors in risk stratification
Michael E Farkouh*, Sameer Bansilal and Verghese Mathew
Correspondence *Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1074, New York, NY 10029, USA
Email michael.farkouh@mssm.edu
In this Viewpoint, Michael Farkouh and colleagues question the evidence that C-reactive protein (CRP) is an independent predictor of future cardiovascular events. They suggest that failure to adjust for all components of the metabolic syndrome (MetS) in previous studies has bought into question the value of CRP over established traditional risk factors. The authors postulate that CRP is only a marker of the MetS and has limited incremental value in cardiovascular risk stratification.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
